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Abstract
Background Preservation of the spleen in distal pancre-
atectomy has recently attracted considerable attention. Our
current study aimed in the first instance to define the safety
of lap-WT in relation to the capacity of this technique to
achieve preservation of the spleen and secondly to inves-
tigate the effectiveness of a planned lap-WT procedure or
early conversion to lap-WT in selected patients with a large
tumor attached to the splenic vessels.
Methods Among 1056 patients who underwent a laparo-
scopic distal pancreatectomy between January 2005 and
December 2014 at our hospital, 122 (24.6 %) underwent
lap-WT which were analyzed. The 122 patients were cat-
egorized into two groups chronologically (early group:
2005–2012, late group: 2013–2014).
Results The median follow-up was 35 months, and the
median operation time was 181 min. The median postop-
erative hospital stay was 7 days, and the median estimated
blood loss was 316 ml. Postoperative complications
occurred in 9 patients (7.3 %), including 4 patients (3.2 %)
with major pancreatic fistula (ISGPF grade B, C). A
reoperation to address postoperative bleeding was needed
in one patient. During a median follow-up of 35 months,
there were no clinical significant splenic infarctions or
gastric varices in any case. All patients were observed
conservatively. In patients in the late group who underwent
the lap-WT, the mean operating time (171 vs. 205 min,
p = 0.001) and mean estimated blood loss (232.1 vs.
370.0 ml, p = 0.017) were significantly less than the early
group cases who received lap-WT.
Conclusions A lap-WT is a safe treatment strategy in
select cases when used as a way of preserving the spleen.
When splenic vessel preservation is technically challeng-
ing, for example when the tumor is enlarged or is attached
to the splenic vessels, planned lap-WT or early conversion
to lap-WT may be a feasible option.
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Laparoscopic distal pancreatectomy (LDP) is a standard
treatment for benign or low-grade malignant pancreatic
tumors of the left-sided pancreas. To reduce the risk of
post-splenectomy sepsis and late hematologic disorders and
malignancy [1, 2], splenic preservation during distal pan-
createctomy (SPDP) for benign or low-grade malignant
disease of pancreas has been proposed. There are two
spleen-preserving SPDP methods: In one, the splenic artery
and vein are preserved, and in the other they are excised.
However, preservation of the splenic artery and vein while
dividing the small branches to the distal pancreas is tech-
nically more challenging. In contrast, a spleen-preserving
distal pancreatectomy involving ligation of both splenic
vessels (the Warshaw procedure) [3, 4] can be performed
safely and effectively.
LDP for the treatment of benign or low-grade malignant
pancreatic body and tail lesions commenced in our hospital
in 2005 [5]. In our previous study, we demonstrated that
the laparoscopic Warshaw technique (lap-WT) can be used
for patients with large and benign or low-grade malignant
tumors that distort and compress the vessel course and
that this approach yields acceptable clinical outcomes
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compared to splenic vessel-preserving LDP (SVP-LDP)
[6]. In our current study, we aimed to use these previous
findings as the basis for an assessment of the long-term,
clinically significant complications associated with lap-WT
and thereby evaluate the safety of this method of preserv-
ing the spleen.
We performed SVP-LDP at our hospital from 2005 to
2012 to treat benign masses in the pancreatic body or tail.
If this surgery was not successful due to the presence of
either a relatively large tumor or splenic vessel involve-
ment, we converted to lap-WT. However, this strategy was
time consuming and was also associated with considerable
blood loss. We therefore adopted a new approach from
2013 to 2014 in which we introduced a much earlier con-
version to lap-WT after a failure of SVP-LDP and per-
formed planned lap-WT procedures in selected patients
because of the presence of either a large tumor or a tumor
attached to the splenic vessels. The second purpose of our
current study was to compare the clinical outcomes
between patients who underwent lap-WT after SVP-LDP
failure and patients who received a planned lap-WT or
early conversion to lap-WT.
Materials and methods
Patients
From November 2005 to December 2014, a total of 1056
patients underwent laparoscopic distal pancreatectomy
(LDP) at our institution (Asan Medical Center, Seoul,
Korea). Of these cases, 495 patients with benign or low-
grade malignant lesions in the body and tail of the pancreas
underwent spleen-preserving LDP among which 122
patients underwent lap-WT for spleen preservation. We
further examined these 122 cases in our present study. A
spleen preservation approach had not been considered
appropriate among the initial 1056 LDP patients with (1)
malignancies on preoperative imaging, (2) severe pancre-
atitis with or without pseudocyst, or (3) a relatively large
tumor located at the hilum of the spleen. Where a malig-
nancy was suspected, a splenectomy was always per-
formed. The 122 patients selected for analysis in this study
were categorized into two groups, according to their
treatment chronology. The early group (EG) included
patients who underwent a conversion to lap-WT between
2005 and 2012 following an SVP-LDP failure. The late
group (LG) comprised patients who underwent either
planned or early conversion to lap-WT from 2013 to 2014.
Demographic data (age, gender, body mass index, and
tumor size), operating procedures and times, postoperative
complications, length of hospital stay, and pathologic
diagnoses were retrospectively compared between the two
groups. The actual spleen preservation rate, which is the
ratio of practical spleen and intended spleen preservation,
was also compared between the two groups.
Surgical procedure and strategy
In all of our current study patients, an open technique was
used to establish pneumoperitoneum through a periumbil-
ical 12-mm trocar used under direct vision. Abdominal
pressure was maintained at 12 mmHg by insufflation of
CO2 gas. This surgical technique has been previously
described in a report from our institution [5]. During the
EG period, SVP-LDP was the first treatment choice for a
benign pancreatic mass at the pancreatic body and tail. The
decision to perform SVR was made intraoperatively, as
only then was it possible to determine whether dissection
of the pancreas from the splenic vessels could be achieved
or whether uncontrolled bleeding was occurring during
SVP-LDP (Fig. 1). The lesser sac was accessed via the
gastrocolic omentum outside of the gastroepiploic arcade,
which was carefully preserved by the surgeon. Retraction
of the stomach and visualization of the body and tail of the
pancreas and the splenic hilum were enabled by division of
the omentum. Dissection was stopped before the short
gastric vessels were reached to protect them from possible
injury. The avascular plane behind the body and tail was
reached by opening the retroperitoneum along the inferior
margin of the pancreas. The splenic artery was then con-
trolled and divided.
Prior to splenic vessel ligation, we used a vascular
clamp to confirm the color of the spleen. When splenic
vessels are clamped, the spleen color is sometimes darker
than it had been before the vascular interruption.
Nonetheless, a dark red color indicative of perfusion and
Fig. 1 Laparoscopic surgical treatment strategies for the patients
with benign or low-grade malignant tumor at left-sided pancreas.
SVP-LDP splenic vessel-preserving laparoscopic distal pancreatec-
tomy, lap-WT laparoscopic Warshaw technique
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viability should still be evident. An area of likely necrosis
is indicated by a sharply demarcated area, dark gray or
black in appearance. This finding may indicate the need for
removal of the spleen, depending on the volume of critical
ischemia. Partial areas of apparent infarction, perhaps less
than 30–40 % of the spleen, do not preclude the use of
SVR. However, during the LG period, if the tumor was
found to be either relatively large or close to the splenic
vessels on preoperative CT imaging, then planned or early
conversion to lap-WT was performed (Fig. 1). Also, if
splenic infarction of more than 50–70 % of the spleen was
identified intraoperatively, then lap-WT was performed
without splenectomy, but only if it was certain that the
short gastric artery and the gastroepiploic artery could be
preserved.
After the splenic artery was clipped and divided, the
inferior border of the pancreas was then freed from the
transverse mesocolon all the way to the tip of the pancre-
atic tail. Once the distal retroperitoneal dissection reached
the splenic hilum, the splenic vascular pedicle was ligated
and divided between the tip of the pancreas and the splenic
hilum. Next, the tail of the pancreas was moved to the
right, the splenic vein was divided, and the pancreas was
transected and removed. The color and viability of the
spleen was reconfirmed before closure of the abdomen.
Complications and follow-up
Preoperative and postoperative computed tomography (CT)
images were compared to evaluate postoperative abdomi-
nal changes, splenic perfusion, and whether vessels were
native or collaterals that developed after surgery. Follow-
ups included a thorough medical examination and a con-
trast-enhanced CT scan at 3 months and then once yearly
assessments following the index operation to assess the
presence of gastric varices and splenic perfusion, and any
additional postoperative complications. Complications
were classified according to the criteria of Clavien and
Dindo [7]. In accordance with the 2005 International Study
Group of Pancreatic Fistula (ISGPF) [8], each pancreatic
fistula was classified as grade A, B, or C [9].
Each radiologic study was reviewed to assess for splenic
infarcts and gastric varices. Splenic infarction volumes
were measured on postoperative CT scan at 3 days, 3 and
12 months by a single, expert radiologist. Splenic perfusion
was grouped into grades on the basis of the percentage of
the total splenic volume affected by the infarction: grade 0,
intact; grade 1, \30 % infarction; grade 2, 30–50 %
infarction; grade 3, 50–70 % infarction; and grade 4,
[70 % infarction. When tortuous vascular structures larger
than 5 mm in diameter were seen, gastric varices were
diagnosed on CT images by the expert radiologist who
assessed the splenic infarction volume. Gastric varices
located along the outside border of the gastric wall were
defined as perigastric varices, and those existing within the
wall of stomach were designated as submucosal gastric
varices. Gastric varices were classified into perigastric and
submucosal gastric type. Perigastric varices were graded
based on measurement of diameter: grade 1, 5–10 mm;
grade 2, 10–20 mm; and grade 3,[20 mm.
Statistical analysis
Continuous variables were expressed as median and range
or mean ± standard deviation. Categorical variables were
reported as numbers and percentages. The AX2 test (with
Yates continuity correction in a 2 9 2 contingency table)
was used for nominal data. Numerical variables were
compared using a Student’s t test. Data were considered
significant at p\ 0.05. SPSS statistical software ver. 17.0
(SPSS, Inc., Chicago, IL) was used for all statistical
analyses.
Results
Operative methods and actual spleen preservation
rate
Essential characteristics of the surgical procedures used in
the current patient series are summarized in Table 1. Of the
1056 patients who underwent laparoscopic distal pancrea-
tectomy at our hospital, 561 patients (52.1 %) underwent a
laparoscopic distal pancreatectomy with splenectomy
(LDPS), 373 patients (35.3 %) underwent a SVP-LDP, and
122 patients (11.6 %) underwent a lap-WT. The actual
spleen preservation rate was 496/613 patients (80.9 %).
Patient characteristics
Table 2 lists the patient characteristics and the pathologic
diagnoses for the 122 cases that underwent lap-WT. The
Table 1 Surgical procedures and actual spleen-preserving rate





Actual spleen-preserving rate* 496/613 (80.9)
LDPS laparoscopic distal pancreaticosplenectomy, SVP-LDP splenic
vessel-preserving laparoscopic distal pancreatectomy, lap-WT
laparoscopic Warshaw technique
* The actual spleen preservation rate, which is the ratio of practical
spleen and intended spleen preservation
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median age of this lap-WT cohort was 48 years (range
38–58), and 83.6 % of the patients were female. The mean
tumor size was 4.1 ± 2.3 cm, and BMI was 23.1 ± 2.9 kg/
m2. The most common diagnosis was a solitary pseu-
dopapillary neoplasm (38 patients, 31.2 %).
Perioperative outcomes
Perioperative outcomes are outlined in Table 3. There were
no perioperative mortality and no conversion to open sur-
gery among the lap-WT patients. The median operation
time for these 122 patients was 181.5 min (range 144–220),
and the median estimated blood loss was 316.7 ml (range
120–493). The median postoperative hospital stay was
7 days (range 6–9). Based on the Clavien–Dindo classifi-
cation, postoperative complications occurred in 9 (7.3 %)
patients, including 3 (2.5 %) cases with intra-abdominal
fluid collection and 4 (3.3 %) patients with grade B or C
pancreatic fistula. On postoperative day 1, one of the study
patients underwent an early reoperation by splenectomy to
control for a postoperative hemorrhage. Another patient
underwent a reoperation on postoperative day 10 to treat a
small bowel strangulation from an incisional hernia.
According to the ISGPF definition, 55 (45.1 %) of our lap-
WT patients had pancreatic fistulas. These were classified
as grade A (n = 51; 41.8 %), B (n = 3; 2.5 %), or C
(n = 1; 0.8 %). A single patient (grade C) showed
postoperative fluid collection and underwent endoscopic
ultrasonography (EUS)-guided gastrocystic drainage.
Long-term clinical outcomes
Table 4 lists the splenic infarction and gastric varices
outcomes in our study cohort. On postoperative day 3, the
rate of splenic infarction by CT scan was 54.2 % (66/122),
and this included grade 1 (n = 30; 24.6 %), 2 (n = 18;
14.8 %), and 3 (n = 18; 14.8 %). No specific treatment for
this complication was administered. On follow-up CT scan
taken within 3 months of the operation, 54/66 (81.8 %)
patients with a splenic infarction recovered, while 62 of
these cases (94.0 %) had recovered within 12 months
(Fig. 2). The remaining 4 patients recovered partially to an
infarction volume of below 10 % of the spleen. During a
median follow-up of 35 months (IQR 19–60), there were
no clinically significant splenic infarctions in our lap-WT
cohort. All patients were observed conservatively. At
12 months post-surgery, a follow-up CT scan revealed
perigastric varices in 25 patients (20.5 %) ranging from
grade 1 (n = 22; 18.0 %) to grade 2 (n = 3; 2.5 %). No
grade 3 varices were identified (Fig. 3). Submucosal gastric
varices also were detected in 10 patients (8.1 %) on CT
scans performed 12 months after surgery. During the fol-
low-up period, there were no instances of gastrointestinal
bleeding from these perigastric varices and submucosal
gastric varices.
Clinical outcomes between the early group (EG)
and the late group (LG) of lap-WT patients
Table 5 compares the outcomes in the EG and LG groups
of lap-WT cases. The median operative time (171.0 vs.
205.0 min, p = 0.001) and median estimated blood loss
(232.1 vs. 370.0, p = 0.017), respectively, were signifi-
cantly different between these two groups. The overall rate
of complications did not differ between the EG and LG
patients (p = 0.377), and no statistically significant dif-
ference was found between the occurrence of a pancreatic
fistula (p = 0.76). In addition, no difference was evident
between the groups in the rates of splenic infarction
(p = 0.742) or perigastric varices (p = 0.448).
Discussion
A splenectomy is associated with a lifetime risk of devel-
oping overwhelming post-splenectomy infection (OPSI),
hematologic disorders, and malignancies [10, 11]. Hence,
spleen preservation during surgery is highly desirable. A
spleen-preserving distal pancreatectomy is thus becoming
the preferred approach for the treatment of pancreatic
Table 2 Characteristics of patients who underwent lap-WT
Patients (n = 122)
Number %
Age at diagnosis (year)




BMI (kg/m2, mean ± SD) 23.1 ± 2.9
Tumor size (cm, Mean ± SD) 4.1 ± 2.3
Pathologic diagnosis








Other diagnosis 2 1.6
MCN mucinous cystic neoplasm, SCN serous cystic neoplasm, IPMN
intrapapillary mucinous neoplasm, SPN solitary pseudopapillary
neoplasm, SD standard deviation
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diseases involving benign or low-grade tumors. This
approach involves conservation of the splenic artery and
vein and is comparatively easy and safe in patients without
severe pancreatitis or a pseudocyst and who do not have a
relatively large tumor located at the hilum of the spleen
[12]. This operation preserves the splenic artery and vein
by dissecting and carefully ligating the multiple, small,
short branches of the splenic vessels that extend to the body
and tail of the pancreas. Notably, however, dissecting the
splenic vessels from the pancreas may be difficult if a large
tumor has attached to the course of these vessels. This may
be especially challenging when a laparoscopic technique is
used. In patients for whom preservation of the splenic
vessels will be technically difficult, it may be prudent to
use lap-WT. In this procedure, the splenic artery and vein
are resected so that the short gastric and left gastroepiploic
vessels are retained to preserve the blood supply to the
spleen.
Among the concerns in relation to adverse outcomes
following lap-WT are spleen-related complications, par-
ticularly splenic infarction. Ferrone et al. [3] have reported
that only 3 of 156 patients (1.9 %) who underwent WT
required a reoperation for a splenic infarction from 3 to
100 days postoperatively, and that abdominal pain and/or
fever had led to these surgeries. Kohan et al. [13] reported
that some degree of splenic hypoperfusion could be
observed at 1 week post-operation in 63 % (22/35) of their
patients who underwent lap-WT. Matsushima and col-
leagues reported that although lap-WT induced a splenic
infarction in 24 % (4/17) of their patients, all of those
infarctions were focal and none required a splenectomy. In
all of the patients in that study, the infarcted volume was
less than 50 % of the spleen [14]. In our present study, the
splenic infarction rate after lap-WT was 54.2 % (66/122).
Infarction of more than 50 % of the spleen (grade 3) was
found in 18 (14.8 %) of our lap-WT patients on CT
imaging on postoperative day 3. Our review of CT images
further showed that splenic perfusion had returned to nor-
mal within 3 months postoperatively in 54/66 (81.8 %)
patients and within 12 months in 62/66 (94.0 %) patients.
Warshaw reported that splenic infarction does not require
an intervention as long as less than one-third of the spleen
is affected [15]. Our present results suggest that splenic
infarction affecting more than 50 % of the spleen after lap-
Table 3 Perioperative
outcomes
Patients (n = 122)
Median operative time (min, IQR) 181.5 (range 144–220)
Median estimated blood loss (ml, IQR) 316.7 (range 120–493)
Median postoperative hospital stay (day, IQR) 7.0 (range 6–9)
Clavien–Dindo classification
I 1 (0.8 %)
II 5 (4.1 %)
IIIa 1 (0.8 %)
IIIb 2 (1.6 %)
Pancreatic fistula (ISPGF)
Grade A 51 (41.8 %)
Grade B 3 (2.5 %)
Grade C 1 (0.8 %)
Conversion rate (%) 0
Postoperative bleeding 1 (0.8 %)
IQR interquartile range, ISPGF International Study Group on Pancreatic Fistula
Table 4 Long-term clinical outcomes
Patients (n = 122)
Number %
Follow-up duration (month, median, IQR) 35 (19–60)
Splenic infarction on 3 days 66 54.2
Grade 1 (0–30 %) 30 24.6
Grade 2 (30–50 %) 18 14.8
Grade 3 (50–70 %) 18 14.8
Grade 4 (70–100 %) 0 0
Recovery on 3 months 54/66 81.8
Recovery on 12 months 62/66 94
Perigastric varices 25 20.5
Grade 1 (5–10 mm) 22 18
Grade 2 (11–20 mm) 3 2.5
Grade 3 (21 mm-) 0 0
Submucosal gastric varices 10 8.1
Gastrointestinal bleeding 2 0
Late complication 10 8.1
IQR interquartile range
Surg Endosc (2016) 30:4057–4064 4061
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WT is acceptable because most of these patients will
recover within 3 months. However, as it is essential that
the gastroepiploic arcade be carefully preserved during lap-
WT surgery, the dissection is stopped before the short
gastric vessels were reached to avoid any injury to the short
gastric artery. However, if such preservation of the short
gastric and gastroepiploic vessels creates any uncertainty, it
may not be safe to attempt to preserve the spleen by lap-
WT.
In clinical practice, gastric varices frequently occur in
patients with SVR. Following ligation of the splenic artery
and vein, the spleen is supplied by the increased blood flow
through the short gastric and left gastroepiploic vessels.
This increased blood flow leads to the gastric varices along
the gastric wall and, as a consequence, can result in gas-
trointestinal bleeding. From a clinical point of view, it is
important to recognize that submucosal gastric varices may
hemorrhage. Perigastric varices also may form into
Fig. 2 A patient with a grade 3
splenic infarction following lap-
WT. A lap-WT was performed
in this case to treat SPN at the
body of the pancreas. A The CT
scan showed a splenic infarction
of greater than 50 % on
postoperative day 3 (white
arrow). B This recovered fully
within 3 months, as indicated on
follow-up CT scan (white arrow
head)
Fig. 3 A A patient with grade 2
perigastric varices following
lap-WT revealed at the
12-month follow-up by CT scan
(white arrow). B At 4 years
postoperatively, perigastric
varices above 10 mm were still
evident in this patient, but there
were no symptoms and no
gastrointestinal bleeding (white
arrow head)
Table 5 Comparision of the outcomes between the early and late lap-WT patient groups
EG (2005–2012) (n = 61) LG (2013–2014) (n = 61) p value
Median operative time (min, IQR) 205.0 (162–239) 171.0 (131–198) 0.001
Median estimated blood loss (ml, IQR) 370.0 (210–599) 232.1 (45–426) 0.017
Median postoperative hospital stay (days, IQR) 7.0 (6–8) 7.0 (6–9) 0.169
Postoperative complication 4 (6.6 %) 5 (8.1 %) 0.377
Pancreatic fistula (ISPGF grade B/C) 2 (3.3 %) 2 (3.3 %) 0.76
Late complication 6 (9.8 %) 4 (6.6 %) 0.393
Splenic infarction 35 (57.3 %) 31 (50.8 %) 0.742
Gastric varices 13 (12.3 %) 12 (19.4 %) 0.448
IQR interquartile range, ISPGF International Study Group on Pancreatic Fistula
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submucosal gastric varices after penetrating the muscularis
externa [16, 17]. In our current study series, perigastric
varices were found in 22 patients (18.0 %), and in 3 cases
(2.5 %) these were greater than 10 mm in diameter. Sub-
mucosal gastric varices also were found in 10 patients
(8.1 %). However, none of our current study patients with
perigastric varices and submucosal gastric varices devel-
oped gastrointestinal bleeding during the follow-up period.
Notably, a previous study from our center [15] also
reported no instances of gastrointestinal bleeding from
gastric varices during a follow-up period of
31 ± 15 months. Ferrone et al. [3] reported following 125
patients for up to 21 years with no bleeding from peri-
gastric varices. Miura et al. [18, 19] did report a single
patient with gastrointestinal bleeding after lap-WT, but still
concluded in 2011 that lap-WT is feasible. However, we
think that patients with not only submucosal gastric varices
but also perigastric varices need further long-term follow-
up with serial CT scan.
In our present study, the median operative blood loss
and median operative time during lap-WT were 316.7 ml
(range 120–493) and 181.5 min (range 144–220), respec-
tively. However, the median operative time for the LG
patients was significantly shorter than that of the EG cases
(171.0 vs. 205.0 min, p = 0.001). The median estimated
blood loss in the LG group also was significantly less than
that in the EG patients (232.1 vs. 370.0 ml, p = 0.017).
Initially, we planned to perform SVP-LDP for the
patients in the EG group and thus did not intend to perform
lap-WT to treat the lesions of the body and tail of the
pancreas in these cases. During the EG period
(2005–2012), when SVP-LDP was our main treatment
focus, we converted to lap-WT only when intraoperative
bleeding occurred or when we found it difficult to preserve
splenic vessels, due to the presence of a large tumor or of a
tumor attached to a splenic vessel. However, the strategy
we used during this period was found to be time consuming
and could also entail a great deal of blood loss. Starting in
2013, we adopted a strategy that incorporated either pre-
planned lap-WT or an early conversion to this method.
This strategy was adopted because we had found it possible
to achieve acceptable clinical outcomes using lap-WT both
for patients with large and benign tumors and in cases of
low-grade malignant tumors that distort and compress the
course of the vessels [6]. After we had altered our surgical
strategy, we achieved improved outcomes in terms of both
the median blood loss and median operative time. Our
actual rate of spleen preservation with this new protocol
has been 80.9 %, and this rate has been increasing since
2013. Nevertheless, SVP-LDP appears to be the preferable
technique. The blood supply to the spleen is well main-
tained, and the danger of splenic necrosis and abscess
formation is reduced by preserving splenic artery and vein.
Therefore, this procedure should be performed when pos-
sible, and for cases of presence of a large tumor or tumor
being attached to a splenic vessel, it should be switched to
a lap-WT [6, 20].
In conclusion, lap-WT is a safe and feasible procedure
to treat lesions of the pancreas and preserve the important
immunological functions of the spleen. In particular, a pre-
planned lap-WT or early conversion to lap-WT may prove
to be available option for patients for whom the preserva-
tion of splenic vessels is technically challenging.
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